Source: Therapeutic Drug Monitoring. Unidades: FORP, FCFRP
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LANCHOTE, Vera Lúcia et al. Factors influencing plasma concentrations of carbamazepine and carbamazepine -10,11 - epoxide in epiletic children and adults. Therapeutic Drug Monitoring, v. 17, n. 1 , p. 47-52, 1995Tradução . . Acesso em: 04 ago. 2024.APA
Lanchote, V. L., Bonato, P. S., Campos, G. M., & Rodrigues, I. (1995). Factors influencing plasma concentrations of carbamazepine and carbamazepine -10,11 - epoxide in epiletic children and adults. Therapeutic Drug Monitoring, 17( 1 ), 47-52.NLM
Lanchote VL, Bonato PS, Campos GM, Rodrigues I. Factors influencing plasma concentrations of carbamazepine and carbamazepine -10,11 - epoxide in epiletic children and adults. Therapeutic Drug Monitoring. 1995 ;17( 1 ): 47-52.[citado 2024 ago. 04 ]Vancouver
Lanchote VL, Bonato PS, Campos GM, Rodrigues I. Factors influencing plasma concentrations of carbamazepine and carbamazepine -10,11 - epoxide in epiletic children and adults. Therapeutic Drug Monitoring. 1995 ;17( 1 ): 47-52.[citado 2024 ago. 04 ]
